←Back to Expert Scholars
Translational Medicine / 转化医学Uveal Melanoma
Takami Sato
MD, PhD
🏢Thomas Jefferson University🌐USA
Professor of Medical Oncology
45
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Takami Sato is a leader in liver directed therapy for uveal melanoma including percutaneous hepatic perfusion with melphalan. His work addresses the liver dominant metastatic pattern unique to uveal melanoma. He has contributed to regulatory approval of PHP therapy.
Share:
🧪Research Fields 研究领域
uveal melanoma
hepatic perfusion
melphalan
liver metastasis
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Takami Sato 的研究动态
Follow Takami Sato's research updates
留下邮箱，当我们发布与 Takami Sato（Thomas Jefferson University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment